{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:06:13Z","timestamp":1784675173612,"version":"3.55.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32 NS07153"],"award-info":[{"award-number":["T32 NS07153"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11886-021-01604-1","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T21:23:06Z","timestamp":1634419386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Stroke Prevention After Cryptogenic Stroke"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8701-8953","authenticated-orcid":false,"given":"Chinwe","family":"Ibeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell S. V.","family":"Elkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"issue":"4","key":"1604_CR1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/STROKEAHA.117.020031","volume":"49","author":"R Ornello","year":"2018","unstructured":"Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke. 2018;49(4):814\u20139.","journal-title":"Stroke"},{"key":"1604_CR2","doi-asserted-by":"crossref","unstructured":"Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh 3rd EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. stroke. 1993 Jan;24(1):35-41.","DOI":"10.1161\/01.STR.24.1.35"},{"issue":"5","key":"1604_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1159\/000210433","volume":"27","author":"P Amarenco","year":"2009","unstructured":"Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009;27(5):502\u20138.","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"1604_CR4","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1161\/STROKEAHA.107.490896","volume":"38","author":"H Ay","year":"2007","unstructured":"Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke. 2007;38(11):2979\u201384.","journal-title":"Stroke"},{"issue":"4","key":"1604_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O\u2019Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet Neurology. 2014;13(4):429\u201338.","journal-title":"The Lancet Neurology"},{"issue":"9","key":"1604_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","volume":"14","author":"L Li","year":"2015","unstructured":"Li L, Yiin GS, Geraghty OC, Schulz UG, Kuker W, Mehta Z, et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol. 2015;14(9):903\u201313.","journal-title":"Lancet Neurol"},{"issue":"20","key":"1604_CR7","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","volume":"380","author":"HC Diener","year":"2019","unstructured":"Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380(20):1906\u201317.","journal-title":"N Engl J Med"},{"issue":"23","key":"1604_CR8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"\u2022\u2022 Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, et al. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018;378(23):2191\u2013201. The RESPECT ESUS trial did not show superiority of the oral anticoagulant rivaroxaban over aspirin therapy for secondary prevention following embolic stroke of undetermined source. The study however provided rationale for two clinical trials examining the efficacy of the oral non-vitamin K antagonist apixaban for secondary prevention in patients with ESUS and evidence of atrial cardiopathy.","journal-title":"N Engl J Med"},{"issue":"17","key":"1604_CR9","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","volume":"382","author":"G Agnelli","year":"2020","unstructured":"\u2022 Agnelli G, Becattini C, Meyer G, Munoz A, Huisman MV, Connors JM, et al. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. N Engl J Med. 2020;382(17):1599\u2013607. Clinical trial demonstrating noninferiority of the oral anticoagulant apixaban compared to subcutaneous dalteparin for the treatment of cancer-associated venous thromboembolism.","journal-title":"N Engl J Med"},{"key":"1604_CR10","doi-asserted-by":"crossref","unstructured":"Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011\u201321.","DOI":"10.1056\/NEJMoa1705915"},{"issue":"11","key":"1604_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L Sondergaard","year":"2017","unstructured":"Sondergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033\u201342.","journal-title":"N Engl J Med"},{"issue":"20","key":"1604_CR12","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","volume":"71","author":"PH Lee","year":"2018","unstructured":"Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO Trial. J Am Coll Cardiol. 2018;71(20):2335\u201342.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1604_CR13","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"4","key":"1604_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","volume":"14","author":"LA Sposato","year":"2015","unstructured":"Sposato LA, Cipriano LE, Saposnik G, Ruiz Vargas E, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015;14(4):377\u201387.","journal-title":"Lancet Neurol"},{"issue":"21","key":"1604_CR15","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","volume":"129","author":"M Brambatti","year":"2014","unstructured":"Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129(21):2094\u20139.","journal-title":"Circulation"},{"issue":"26","key":"1604_CR16","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478\u201386.","journal-title":"N Engl J Med"},{"issue":"26","key":"1604_CR17","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467\u201377.","journal-title":"N Engl J Med"},{"issue":"5","key":"1604_CR18","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/STROKEAHA.114.007763","volume":"46","author":"CG Favilla","year":"2015","unstructured":"Favilla CG, Ingala E, Jara J, Fessler E, Cucchiara B, Messe SR, et al. Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke. 2015;46(5):1210\u20135.","journal-title":"Stroke"},{"issue":"11","key":"1604_CR19","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.amjcard.2013.01.335","volume":"111","author":"S Suzuki","year":"2013","unstructured":"Suzuki S, Sagara K, Otsuka T, Kano H, Matsuno S, Takai H, et al. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol. 2013;111(11):1602\u20137.","journal-title":"Am J Cardiol"},{"key":"1604_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ahj.2019.09.009","volume":"219","author":"SZ Diederichsen","year":"2020","unstructured":"\u2022 Diederichsen SZ, Haugan KJ, Brandes A, Graff C, Krieger D, Kronborg C, et al. Incidence and predictors of atrial fibrillation episodes as detected by implantable loop recorder in patients at risk: from the LOOP study. Am Heart J. 2020;219:117\u201327. This sub-study of the LOOP study provides evidence of biomarkers associated with incident atrial fibrillation among patients with implantable loop recorders.","journal-title":"Am Heart J"},{"key":"1604_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2020.11.019","volume":"327","author":"D Marks","year":"2021","unstructured":"Marks D, Ho R, Then R, Weinstock JL, Teklemariam E, Kakadia B, et al. Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: the value of p wave dispersion in predicting arrhythmia occurrence. Int J Cardiol. 2021;327:86\u201392.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1604_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"\u2022\u2022 Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120\u20139. This secondary analysis of NAVIGATE ESUS provides evidence that the direct acting oral anticoagulant rivaroxaban reduces the risk of recurrent stroke in patients with embolic stroke of undetermined source with evidence of left atrial enlargement.","journal-title":"N Engl J Med"},{"issue":"8","key":"1604_CR23","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1212\/WNL.0000000000000145","volume":"82","author":"A Culebras","year":"2014","unstructured":"Culebras A, Messe SR, Chaturvedi S, Kase CS, Gronseth G. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(8):716\u201324.","journal-title":"Neurology"},{"issue":"5","key":"1604_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"5","key":"1604_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.24482","volume":"78","author":"H Kamel","year":"2015","unstructured":"Kamel H, O\u2019Neal WT, Okin PM, Loehr LR, Alonso A, Soliman EZ. Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study. Ann Neurol. 2015;78(5):670\u20138.","journal-title":"Ann Neurol"},{"issue":"4","key":"1604_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","volume":"44","author":"AR Folsom","year":"2013","unstructured":"Folsom AR, Nambi V, Bell EJ, Oluleye OW, Gottesman RF, Lutsey PL, et al. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke. 2013;44(4):961\u20137.","journal-title":"Stroke"},{"issue":"6","key":"1604_CR27","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/STROKEAHA.115.008711","volume":"46","author":"S Yaghi","year":"2015","unstructured":"Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke. 2015;46(6):1488\u201393.","journal-title":"Stroke"},{"issue":"7","key":"1604_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jamaneurol.2019.0617","volume":"76","author":"JS Healey","year":"2019","unstructured":"Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE, et al. Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial. JAMA Neurol. 2019;76(7):764\u201373.","journal-title":"JAMA Neurol"},{"issue":"7","key":"1604_CR29","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.104.524371","volume":"112","author":"S Homma","year":"2005","unstructured":"Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005;112(7):1063\u201372.","journal-title":"Circulation"},{"issue":"7","key":"1604_CR30","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/STROKEAHA.109.547828","volume":"40","author":"AA Alsheikh-Ali","year":"2009","unstructured":"Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40(7):2349\u201355.","journal-title":"Stroke"},{"issue":"12","key":"1604_CR31","first-page":"1865","volume":"24","author":"L Cabanes","year":"1993","unstructured":"Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography Stroke. 1993;24(12):1865\u201373.","journal-title":"A study using transesophageal echocardiography Stroke"},{"issue":"7","key":"1604_CR32","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","volume":"81","author":"DM Kent","year":"2013","unstructured":"Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619\u201325.","journal-title":"Neurology"},{"issue":"5","key":"1604_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.12.001","volume":"18","author":"L Caputi","year":"2009","unstructured":"Caputi L, Carriero MR, Falcone C, Parati E, Piotti P, Materazzo C, et al. Transcranial Doppler and transesophageal echocardiography: comparison of both techniques and prospective clinical relevance of transcranial Doppler in patent foramen ovale detection. J Stroke Cerebrovasc Dis. 2009;18(5):343\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1604_CR34","doi-asserted-by":"crossref","first-page":"8701759","DOI":"10.1155\/2020\/8701759","volume":"2020","author":"X Yang","year":"2020","unstructured":"\u2022 Yang X, Wang H, Wei Y, Zhai N, Liu B, Li X. diagnosis of patent foramen ovale: the combination of contrast transcranial doppler, contrast transthoracic echocardiography, and contrast transesophageal echocardiography. Biomed Res Int. 2020;2020:8701759. This study provides evidence for a practical approach to the evaluation of PFOs, combining the applications of contrast TCD, contrast TTE and contrast TEE.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1604_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1161\/01.STR.0000106137.42649.AB","volume":"35","author":"SC Cramer","year":"2004","unstructured":"Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke. 2004;35(1):46\u201350.","journal-title":"Stroke"},{"issue":"8","key":"1604_CR36","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0002-9149(97)00604-8","volume":"80","author":"H Lethen","year":"1997","unstructured":"Lethen H, Flachskampf FA, Schneider R, Sliwka U, Kohn G, Noth J, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol. 1997;80(8):1066\u20139.","journal-title":"Am J Cardiol"},{"issue":"11","key":"1604_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991\u20139.","journal-title":"N Engl J Med"},{"issue":"12","key":"1604_CR38","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083\u201391.","journal-title":"N Engl J Med"},{"issue":"12","key":"1604_CR39","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092\u2013100.","journal-title":"N Engl J Med"},{"issue":"5","key":"1604_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/M17-3033","volume":"168","author":"S De Rosa","year":"2018","unstructured":"De Rosa S, Sievert H, Sabatino J, Polimeni A, Sorrentino S, Indolfi C. Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis. Ann Intern Med. 2018;168(5):343\u201350.","journal-title":"Ann Intern Med"},{"issue":"20","key":"1604_CR41","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1212\/WNL.0000000000009443","volume":"94","author":"SR Messe","year":"2020","unstructured":"\u2022\u2022 Messe SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology. Neurology. 2020;94(20):876\u201385. This advisory update provides the most recent AAN recommendations on secondary prevention for patients with cryptogenic stroke and PFO.","journal-title":"Neurology"},{"issue":"8","key":"1604_CR42","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254\u2013743.","journal-title":"Circulation"},{"issue":"10","key":"1604_CR43","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1161\/STROKEAHA.111.628479","volume":"42","author":"KG Haeusler","year":"2011","unstructured":"Haeusler KG, Laufs U, Endres M. Chronic heart failure and ischemic stroke. Stroke. 2011;42(10):2977\u201382.","journal-title":"Stroke"},{"issue":"1","key":"1604_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.09.002","volume":"19","author":"P Pullicino","year":"2010","unstructured":"Pullicino P, Homma S. Stroke in heart failure: atrial fibrillation revisited? J Stroke Cerebrovasc Dis. 2010;19(1):1\u20132.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1604_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijcard.2017.07.056","volume":"248","author":"SH Kang","year":"2017","unstructured":"Kang SH, Kim J, Park JJ, Oh IY, Yoon CH, Kim HJ, et al. Risk of stroke in congestive heart failure with and without atrial fibrillation. Int J Cardiol. 2017;248:182\u20137.","journal-title":"Int J Cardiol"},{"key":"1604_CR46","doi-asserted-by":"crossref","unstructured":"Lip GY, Ponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, et al. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis. Eur J Heart Fail. 2012;14(7):681\u201395.","DOI":"10.1093\/eurjhf\/hfs073"},{"issue":"12","key":"1604_CR47","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","volume":"119","author":"BM Massie","year":"2009","unstructured":"Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009;119(12):1616\u201324.","journal-title":"Circulation"},{"issue":"20","key":"1604_CR48","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","volume":"366","author":"S Homma","year":"2012","unstructured":"Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366(20):1859\u201369.","journal-title":"N Engl J Med"},{"issue":"14","key":"1604_CR49","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","volume":"379","author":"F Zannad","year":"2018","unstructured":"\u2022 Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, et al. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. N Engl J Med. 2018;379(14):1332\u201342. COMMANDER-HF compared the addition of low dose rivaroxaban versus placebo to standard therapy in patients with chronic ischemic heart failure. The trial found no difference in either the primary outcome of death, myocardial infarction, or stroke or the primary safety outcome.","journal-title":"N Engl J Med"},{"issue":"44","key":"1604_CR50","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/eurheartj\/ehz427","volume":"40","author":"MR Mehra","year":"2019","unstructured":"\u2022 Mehra MR, Vaduganathan M, Fu M, Ferreira JP, Anker SD, Cleland JGF, et al. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J. 2019;40(44):3593\u2013602. This post hoc analysis of the COMMANDER-HF trial provides evidence that the addition of low-dose rivaroxaban to a background of standard medical therapy may help reduce the risk of stroke in patients with chronic ischemic heart failure without increased risk of major bleeding.","journal-title":"Eur Heart J"},{"issue":"3","key":"1604_CR51","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.STR.0000204638.91099.91","volume":"37","author":"N Takaya","year":"2006","unstructured":"Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI\u2013initial results. Stroke. 2006;37(3):818\u201323.","journal-title":"Stroke"},{"key":"1604_CR52","doi-asserted-by":"crossref","unstructured":"Gupta A, Gialdini G, Lerario MP, Baradaran H, Giambrone A, Navi BB, et al. Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke. J Am Heart Assoc. 2015;4(6):e002012.","DOI":"10.1161\/JAHA.115.002012"},{"issue":"2","key":"1604_CR53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00259-015-3201-8","volume":"43","author":"F Hyafil","year":"2016","unstructured":"Hyafil F, Schindler A, Sepp D, Obenhuber T, Bayer-Karpinska A, Boeckh-Behrens T, et al. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET\/MR imaging. Eur J Nucl Med Mol Imaging. 2016;43(2):270\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"19","key":"1604_CR54","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.21037\/atm-2020-cass-16","volume":"8","author":"M Kassem","year":"2020","unstructured":"\u2022 Kassem M, Florea A, Mottaghy FM, van Oostenbrugge R, Kooi ME. Magnetic resonance imaging of carotid plaques: current status and clinical perspectives. Ann Transl Med. 2020;8(19):1266. Excellent review of advancements in carotid MRI imaging techniques and applications.","journal-title":"Ann Transl Med"},{"issue":"4","key":"1604_CR55","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neurad.2016.12.004","volume":"44","author":"W Brinjikji","year":"2017","unstructured":"Brinjikji W, Lehman VT, Kallmes DF, Rabinstein AA, Lanzino G, Murad MH, et al. The effects of statin therapy on carotid plaque composition and volume: a systematic review and meta-analysis. J Neuroradiol. 2017;44(4):234\u201340.","journal-title":"J Neuroradiol"},{"issue":"13","key":"1604_CR56","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa043033","volume":"352","author":"MI Chimowitz","year":"2005","unstructured":"Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"1604_CR57","first-page":"91","volume":"48","author":"S Gaskie","year":"1999","unstructured":"Gaskie S. Carotid endarterectomy for symptomatic moderate stenosis. J Fam Pract. 1999;48(2):91\u20132.","journal-title":"J Fam Pract"},{"issue":"7","key":"1604_CR58","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S1474-4422(04)00806-3","volume":"3","author":"MR Macleod","year":"2004","unstructured":"Macleod MR, Amarenco P, Davis SM, Donnan GA. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol. 2004;3(7):408\u201314.","journal-title":"Lancet Neurol"},{"issue":"22","key":"1604_CR59","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJM199412013312202","volume":"331","author":"P Amarenco","year":"1994","unstructured":"Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331(22):1474\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"1604_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJM199201233260402","volume":"326","author":"P Amarenco","year":"1992","unstructured":"Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med. 1992;326(4):221\u20135.","journal-title":"N Engl J Med"},{"issue":"12","key":"1604_CR61","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/S0002-9149(02)02870-9","volume":"90","author":"PA Tunick","year":"2002","unstructured":"Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002;90(12):1320\u20135.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1604_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0735-1097(97)00449-X","volume":"31","author":"FA Dressler","year":"1998","unstructured":"Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol. 1998;31(1):134\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1604_CR63","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/STROKEAHA.113.004251","volume":"45","author":"P Amarenco","year":"2014","unstructured":"Amarenco P, Davis S, Jones EF, Cohen AA, Heiss WD, Kaste M, et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke. 2014;45(5):1248\u201357.","journal-title":"Stroke"},{"issue":"1","key":"1604_CR64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00005792-198501000-00002","volume":"64","author":"F Graus","year":"1985","unstructured":"Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore). 1985;64(1):16\u201335.","journal-title":"Medicine (Baltimore)"},{"key":"1604_CR65","unstructured":"Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Altekruse S, et al. SEER Cancer Statistics Review, 1975\u20132013.: National Cancer Institute. Bethesda, MD; 2016."},{"issue":"1","key":"1604_CR66","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00415-015-7954-6","volume":"263","author":"M Kneihsl","year":"2016","unstructured":"Kneihsl M, Enzinger C, Wunsch G, Khalil M, Culea V, Urbanic-Purkart T, et al. Poor short-term outcome in patients with ischaemic stroke and active cancer. J Neurol. 2016;263(1):150\u20136.","journal-title":"J Neurol"},{"issue":"5","key":"1604_CR67","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25227","volume":"83","author":"BB Navi","year":"2018","unstructured":"Navi BB, Iadecola C. Ischemic stroke in cancer patients: a review of an underappreciated pathology. Ann Neurol. 2018;83(5):873\u201383.","journal-title":"Ann Neurol"},{"issue":"2","key":"1604_CR68","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1212\/CPJ.0000000000000603","volume":"9","author":"AM Nouh","year":"2019","unstructured":"\u2022 Nouh AM, Staff I, Finelli PF. Three Territory Sign: An MRI marker of malignancy-related ischemic stroke (Trousseau syndrome). Neurol Clin Pract. 2019;9(2):124\u20138. This study provides evidence associating the appearance of three territory involvement on DWI-MRI with malignancy-related stroke.","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"1604_CR69","first-page":"779","volume":"54","author":"E Dardiotis","year":"2019","unstructured":"Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, et al. Cancer-associated stroke: pathophysiology, detection and management (Review). Int J Oncol. 2019;54(3):779\u201396.","journal-title":"Int J Oncol"},{"issue":"4","key":"1604_CR70","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.022","volume":"23","author":"YJ Guo","year":"2014","unstructured":"Guo YJ, Chang MH, Chen PL, Lee YS, Chang YC, Liao YC. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study. J Stroke Cerebrovasc Dis. 2014;23(4):e249\u201354.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"1604_CR71","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","volume":"20","author":"D Farge","year":"2019","unstructured":"Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, et al. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2019;20(10):e566\u201381.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1604_CR72","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):496\u2013520.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1604_CR73","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533\u20134.","journal-title":"Lancet Infect Dis"},{"key":"1604_CR74","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Siow I, Lee KS, Zhang JJY, Saffari SE, Ng A, Young B. Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors. J Stroke Cerebrovasc Dis. 2021;30(3):105549. Review and meta-analysis of 30 international studies discussing the incidence, predictors and mortality of COVID 19-related ischemic stroke.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105549"},{"issue":"4","key":"1604_CR75","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/acn3.545","volume":"5","author":"AK Boehme","year":"2018","unstructured":"Boehme AK, Luna J, Kulick ER, Kamel H, Elkind MSV. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018;5(4):456\u201363.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1604_CR76","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/01.STR.0000202624.89869.e9","volume":"37","author":"MS Elkind","year":"2006","unstructured":"Elkind MS, Tondella ML, Feikin DR, Fields BS, Homma S, Di Tullio MR. Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke. 2006;37(3):790\u20135.","journal-title":"Stroke"},{"key":"1604_CR77","doi-asserted-by":"crossref","unstructured":"Ohland J, Warren-Gash C, Blackburn R, M\u00f8lbak K, Valentiner-Branth P, Nielsen J, Emborg HD. Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016. Eurosurveillance. 2020 Apr 30;25(17):1900199.","DOI":"10.2807\/1560-7917.ES.2020.25.17.1900199"},{"issue":"25","key":"1604_CR78","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa041747","volume":"351","author":"L Smeeth","year":"2004","unstructured":"Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611\u20138.","journal-title":"N Engl J Med"},{"key":"1604_CR79","doi-asserted-by":"crossref","unstructured":"\u2022 Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, et al. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 2020. This analysis from a single academic medical center during the height of the corona virus pandemic provides evidence that the risk of stroke after COVID-19 is higher than it was after influenza during prior years.","DOI":"10.1001\/jamaneurol.2020.2730"},{"issue":"9","key":"1604_CR80","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s00277-020-04182-4","volume":"99","author":"A Allegra","year":"2020","unstructured":"Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol. 2020;99(9):1953\u201365.","journal-title":"Ann Hematol"},{"key":"1604_CR81","doi-asserted-by":"crossref","unstructured":"Yamakawa M, Kuno T, Mikami T, Takagi H, Gronseth G. Clinical characteristics of stroke with COVID-19: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020;29(12):105288.","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105288"},{"issue":"7","key":"1604_CR82","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/STROKEAHA.120.030335","volume":"51","author":"S Yaghi","year":"2020","unstructured":"Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51(7):2002\u201311.","journal-title":"Stroke"},{"issue":"1","key":"1604_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12883-021-02075-1","volume":"21","author":"ME Ramos-Araque","year":"2021","unstructured":"Ramos-Araque ME, Siegler JE, Ribo M, Requena M, Lopez C, de Lera M, et al. Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry. BMC Neurol. 2021;21(1):43.","journal-title":"BMC Neurol"},{"issue":"7","key":"1604_CR84","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/1747493020943815","volume":"15","author":"K South","year":"2020","unstructured":"South K, McCulloch L, McColl BW, Elkind MS, Allan SM, Smith CJ. Preceding infection and risk of stroke: an old concept revived by the COVID-19 pandemic. Int J Stroke. 2020;15(7):722\u201332.","journal-title":"Int J Stroke"},{"key":"1604_CR85","unstructured":"Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021 Aug 4. Epub ahead of print."},{"issue":"1","key":"1604_CR86","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12883-020-01969-w","volume":"20","author":"A Nouh","year":"2020","unstructured":"\u2022 Nouh A, Mehta T, Hussain M, Song X, Ollenschleger M. Clot composition of embolic strokes of undetermined source: a feasibility study. BMC Neurol. 2020;20(1):383. (This study provides preliminary evidence correlating red cell-to-platelet ratios with stroke etiology in endovascularly-retrieved intracranial clots.)","journal-title":"BMC Neurol"},{"issue":"1","key":"1604_CR87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/WCO.0000000000000786","volume":"33","author":"S Falcione","year":"2020","unstructured":"Falcione S, Kamtchum-Tatuene J, Sykes G, Jickling GC. RNA expression studies in stroke: what can they tell us about stroke mechanism? Curr Opin Neurol. 2020;33(1):24\u20139.","journal-title":"Curr Opin Neurol"},{"key":"1604_CR88","doi-asserted-by":"crossref","unstructured":"Dykstra-Aiello C, Sharp FR, Jickling GC, Hull H, Hamade F, Shroff N, et al. Alternative splicing of putative stroke\/vascular risk factor genes expressed in blood following ischemic stroke is sexually dimorphic and cause-specific. Front Neurol. 2020;11:584695.","DOI":"10.3389\/fneur.2020.584695"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01604-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01604-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01604-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:10:09Z","timestamp":1744153809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01604-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1604"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01604-1","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]},"assertion":[{"value":"26 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Elkind declares receipt of research funding in kind from the BMS-Pfizer Alliance for Eliquis\u00ae and research funding, but no personal compensation, from Roche, both for a National Institutes of Health-funded trial of stroke prevention; and royalties from UpToDate for chapters on cryptogenic stroke and COVID-19. Dr. Ibeh declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain primary reporting of any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"174"}}